WebJul 9, 2024 · The combination therapy is relatively safe. Conclusion: Ezetimibe add-on to statin combination therapy is an effective treatment option that leads to additional LDL-C … WebLipitor ( atorvastatin) and Zetia ( ezetimibe) are used to lower cholesterol levels in the blood. Lipitor and Zetia belong to different drug classes. Lipitor is an HMG-CoA reductase inhibitor (a “statin” drug) and Zetia is a cholesterol -lowering drug. Side effects of Lipitor and Zetia that are similar include diarrhea and joint pain.
Zetia (ezetimibe): Basics, Side Effects & Reviews - GoodRx
WebMar 18, 2024 · Never stop taking a statin without talking to your doctor first. Commonly reported side effects of statins include: Headaches Nausea Muscle and joint aches However, studies comparing statins to a fake pill (placebo) have found a very small difference in the number of people reporting muscle aches between the groups. WebThe most safe/efficacious dosages of ascending doses of evolocumab have been tested in pharmacodynamic and pharmacokinetic studies performed in patients using stable doses of statins. 40. ... The LAPLACE-TIMI 57 study evaluated different doses of evolocumab together with statin ± ezetimibe, but no serious adverse events occurred. st mary\u0027s church brighstone isle of wight
Ezetimibe: MedlinePlus Drug Information
WebIntroduction. A high level of low-density lipoprotein cholesterol (LDL-C), especially if small and dense, is one of the main risk factors leading to cardiovascular diseases and death. 1 Statins, thanks to their role in inhibiting 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, are the chief drugs used worldwide to lower such a risk. 2 Side effects of … WebEzetimibe is used together with lifestyle changes (diet, weight-loss, exercise) to reduce the amount of cholesterol (a fat-like substance) and other fatty substances in the blood. It may be used alone or in combination with an HMG-CoA reductase inhibitor (statin). Ezetimibe is in a class of medications called cholesterol-lowering medications. WebNov 17, 2024 · Recent studies of non-statin cholesterol lowering drugs (i.e., ezetimibe, PCSK9 inhibitors) have demonstrated cardiovascular benefits; and new drugs [i.e., bempedoic acid (BDA), inclisiran] have produced promising results in pre-clinical and clinical outcome trials. ... Though ezetimibe is regarded as a safe and effective treatment option … st mary\u0027s church bridgwater